InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: jakedogman1 post# 332414

Tuesday, 12/03/2019 9:58:19 PM

Tuesday, December 03, 2019 9:58:19 PM

Post# of 346000
All those trials with Merck and Bavituximab ...nice

Thanks for the reminder Jake and I wonder how Mr Weissman would do in a deposition to go on the record with Peregrine Pharmaceuticals talks with Merck...looks like Merck never really could handle not being able to deal with Steve King and they had other plans to wait for the IP assets and Biomarkers

___


Stephen Weissman

Merck & Co., Inc. in its oncology collaboration with AstraZeneca, and its acquisitions of Peloton Therapeutics and Immune Design Corp.

Merck & Co., Inc. in various acquisitions and potential acquisitions, in the company's defense of competition law claims in various jurisdictions

https://www.bakerbotts.com/people/w/weissman-stephen?tab=experience
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News